文献速递功能神经外科

重复且广泛聚焦超声介导的双侧额叶血脑屏障开放治疗阿尔茨海默病

Repetitive and extensive focused ultrasound-mediated bilateral frontal blood-brain barrier opening for Alzheimer's disease.
PubMed 文献 · J Neurosurg · 2025-01-10

这项开放标签前瞻性研究纳入6例阿尔茨海默病患者,每2个月一次、共三次进行聚焦超声介导的双侧额叶血脑屏障开放,评估安全性和获益。结果未见急性治疗相关不良事件,血脑屏障开放面积平均43.1 cm³,4例(67%)淀粉样斑块平均减少14.9 Centiloid,5例(83%)神经精神症状改善。

要点

  • 6例患者完成三次聚焦超声血脑屏障开放,无急性治疗相关不良事件。
  • 血脑屏障开放面积平均43.1 cm³,约为作者既往研究开放体积(平均20 cm³)的两倍以上。
  • 4/6例(67%)淀粉样斑块平均减少14.9 Centiloid,5/6例(83%)神经精神症状改善。

核心结论

  • 研究证实了在阿尔茨海默病患者中多次进行更频繁、更广泛的双侧额叶血脑屏障开放的安全性和有效性。
  • 这是首个临床试验证明仅通过血脑屏障开放、不联合抗体药物即可改善神经精神症状。

研究设计与样本

  • 开放标签前瞻性研究,2022年6月至2023年7月纳入6例阿尔茨海默病患者。
  • 聚焦超声介导的血脑屏障开放每2个月一次、共三次,靶向双侧额叶。
  • 第一次操作前和第三次操作后行18F-florbetaben正电子发射断层扫描(FBB-PET),并完成神经心理和神经精神评估。

主要发现

  • 全部6例参与者完成研究,无急性治疗相关不良事件。
  • 对比增强MRI证实广泛血脑屏障开放面积平均43.1 cm³,超过作者既往研究开放体积(平均20 cm³)的两倍。
  • FBB-PET显示6例中4例(67%)淀粉样斑块平均减少14.9 Centiloid,但2例参与者血脑屏障开放后淀粉样斑块较基线增加。
  • 韩国版简易精神状态检查在两组均未见显著变化。
  • 照料者版神经精神量表评分在6例中5例(83%)改善,提示神经精神症状改善。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Focused ultrasound (FUS)-mediated blood-brain barrier (BBB) opening is safe and potentially beneficial in patients with Alzheimer's disease (AD) for the removal of amyloid-beta (Aβ) plaques. However, the optimal BBB opening intervals and number of treatment sessions for clinical improvement remain undefined. Therefore, the aim of this study was to evaluate the safety and benefits of repeated and more extensive BBB opening alone. METHODS: In this open-label prospective study, 6 patients with AD were enrolled from June 2022 to July 2023. FUS-mediated BBB opening was performed three times at 2-month intervals targeting the bilateral frontal lobes. 18F-florbetaben positron emission tomography (FBB-PET) was performed before the first procedure and after the third procedure. Patients were administered neuropsychological and neuropsychiatric evaluations. RESULTS: All 6 participants completed the study without any acute treatment-related adverse events. An extensive area of BBB opening (mean 43.1 cm3), more than twice as large as the opening volume (mean 20 cm3) in the authors' previous study, was confirmed by contrast-enhanced MRI. FBB-PET scans demonstrated a 14.9-Centiloid average decrease in Aβ plaques in 4 of the 6 participants (67%), but the Aβ plaques increased in 2 participants after BBB opening, compared with baseline. No significant changes were observed in the Korean version of the Mini-Mental State Examination in either group. Caregiver-Administered Neuropsychiatric Inventory scores improved in 5 of 6 participants (83%), indicating an improvement in neuropsychiatric symptoms. CONCLUSIONS: This study confirmed the safety and efficacy of more frequent and extensive bilateral frontal BBB opening over multiple sessions in patients with AD. Furthermore, this is the first clinical trial to demonstrate improvement in neuropsychiatric symptoms through BBB opening alone, without concurrent administration of antibody medications.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ye BS, Chang KW, Kang S, et al. Repetitive and extensive focused ultrasound-mediated bilateral frontal blood-brain barrier opening for Alzheimer's disease. J Neurosurg. 2025. PMID: 39793012. doi:10.3171/2024.8.JNS24989

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。